Disparities in cancer screening in individuals with a family history of breast or colorectal cancer

Ponce, Ninez A.; Tsui, Jennifer; Knight, Sara J.; Afable-Munsuz, Aimee; Ladabaum, Uri; Hiatt, Robert A.; Haas, Jennifer S.

doi:10.1002/cncr.26480

Cited by 31 publications

(32 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Access to a physician and having a physician recommend screenings are important predictors of screening behavior [8,9,12,13,22]. Due to age and insurance laws in Hawaii, our population most likely had access to health care.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Ethnic differences and predictors of colonoscopy, prostate-specific antigen, and mammography screening participation in the multiethnic cohort

Harmon

Little

Woekel

et al. 2014

Cancer Epidemiology

View full text Add to dashboard Cite

Purpose Given the relation between screening and improved cancer outcomes and the persistence of ethnic disparities in cancer mortality, we explored ethnic differences in colonoscopy, prostate-specific antigen (PSA), and mammography screening in the Multiethnic Cohort Study. Methods Logistic regression was applied to examine the influence of ethnicity as well as demographics, lifestyle factors, comorbidities, family history of cancer, and previous screening history on self-reported screening participation collected in 1999–2002. Results The analysis included 140,398 participants who identified as white, African American, Native Hawaiian, Japanese American, US born-Latino, or Mexican born-Latino. The screening prevalences overall were mammography: 88% of women, PSA: 45% of men, and colonoscopy: 35% of men and women. All minority groups reported 10–40% lower screening utilization than whites, but Mexican-born Latinos and Native Hawaiian were lowest. Men were nearly twice as likely to have a colonoscopy (OR = 1.94, 95% CI = 1.89–1.99) as women. A personal screening history, presence of comorbidities, and family history of cancer predicted higher screening utilization across modalities, but to different degrees across ethnic groups. Conclusions This study confirms previously reported sex differences in colorectal cancer screening and ethnic disparities in screening participation. The findings suggest it may be useful to include personal screening history and family history of cancer into counseling patients about screening participation.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Interactions between ethnicity and these factors have emerged as areas of interest [13,22–25]. The purpose of the current study was to examine how ethnicity and other factors influence colonoscopy, PSA, and mammography screening among participants of the Multiethnic Cohort (MEC).…”

Section: Introductionmentioning

confidence: 99%

Ethnic differences and predictors of colonoscopy, prostate-specific antigen, and mammography screening participation in the multiethnic cohort

Harmon

Little

Woekel

et al. 2014

Cancer Epidemiology

View full text Add to dashboard Cite

show abstract

“…Although previous studies have identifi ed low breast cancer screening uptake in underserved women, 22,23 a populationbased study of individuals with a family history of breast cancer found no signifi cant racial/ethnic or income disparities in uptake of breast cancer screening. 24 It is possible that the strong family histories of breast cancer in our survey population made these women and their health care providers especially attentive to breast cancer screen- Odds ratios less than 1.0 indicate variables independently associated with decreased self-reported general health.…”

Section: Discussionmentioning

confidence: 97%

Genetic Counseling, Cancer Screening, Breast Cancer Characteristics, and General Health among a Diverse Population of BRCA Genetic Testers

Beattie¹,

Copeland²,

Fehniger³

et al. 2013

hpu

View full text Add to dashboard Cite

Outcomes after genetic testing for hereditary breast and ovarian cancer (HBOC) syndrome have not been well studied in underserved populations. We surveyed 1,123 BRCA testers from a genetic counseling program serving an academic cancer center (n=1,045) and a public county hospital (n=78) a median of 3.7 years after testing for mutations in BRCA1 and BRCA2 (breast cancer susceptibility genes). We compared genetic counseling outcomes, cancer screening rates, and self-reported general health. We found no differences in genetic counseling outcomes between hospitals. Breast cancer screening rates were similarly high at both hospitals, which are warranted in this high-risk population. Screening rates for ovarian, colon, and skin cancer were significantly lower in participants from the public hospital. BRCA results were not a predictor of general health at either hospital. When creating a genetic counseling program that serves women in different hospital settings, providers should emphasize guidelines-based screening recommendations for all patients.

show abstract

“…For diverse populations, our findings document racial/ethnic and social gaps in access to and use of PM diagnostics. One reason may be because a perception of one's family history risk may vary by race/ethnicity (Ponce et al 2012). On the supply side, PM diagnostics, such as GEP to inform use of adjuvant chemotherapy for early-stage breast cancer, have not been adequately validated in minority populations (Odierna et al 2011).…”

Section: Diffusion Of Personalized Medicinementioning

confidence: 99%

Economic Perspectives on Personalized Health Care and Prevention

Phillips

Sakowski²,

Liang³

et al. 2013

Forum for Health Economics and Policy

Self Cite

View full text Add to dashboard Cite

The objective of this paper is to provide an overview of economic evaluation of personalized medicine, focusing particularly on the use of costeffectiveness analysis and other methods of valuation. We draw on insights from the literature and our work at the University of California, San Francisco Center for Translational and Policy Research on Personalized Medicine (TRANSPERS). We begin with a discussion of why personalized medicine is of interest and challenges to adoption, whether personalized medicine is different enough to require different evaluation approaches, and what is known about the economics of personalized medicine. We then discuss insights from TRANSPERS research and six areas for future research:1.

show abstract

Disparities in cancer screening in individuals with a family history of breast or colorectal cancer

Cited by 31 publications

References 47 publications

Ethnic differences and predictors of colonoscopy, prostate-specific antigen, and mammography screening participation in the multiethnic cohort

Ethnic differences and predictors of colonoscopy, prostate-specific antigen, and mammography screening participation in the multiethnic cohort

Genetic Counseling, Cancer Screening, Breast Cancer Characteristics, and General Health among a Diverse Population of BRCA Genetic Testers

Economic Perspectives on Personalized Health Care and Prevention

Contact Info

Product

Resources

About